Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis.

Schizophrenia bulletin open·2026
Same author

Attention and learning strategies reveal distinct dimensions of psychiatric diseases.

Research square·2026
Same author

Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples.

The American journal of psychiatry·2026
Same author

Exploring Group Differences in Attenuated Symptoms and Functioning Between Clinical High-Risk Individuals With and Without Posttraumatic Stress Disorder.

Early intervention in psychiatry·2026
Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026
Same author

QuNex recipes: Executable, human-readable workflows for reproducible neuroimaging research.

Imaging neuroscience (Cambridge, Mass.)·2026

Related Experiment Video

Updated: May 16, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.2K

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.

Michael P Harms1, Kang-Ik K Cho2, Alan Anticevic3

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA. mharms@wustl.edu.

Schizophrenia (Heidelberg, Germany)
|April 2, 2025
PubMed
Summary

This study details a neuroimaging protocol for individuals at clinical high risk (CHR) for psychosis, aiming to identify brain biomarkers. Results show participant variance is key for structural and fMRI, but scanner differences impact diffusion imaging quality.

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.4K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.4K

Related Experiment Videos

Last Updated: May 16, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.2K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.4K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.4K

Area of Science:

  • Neuroimaging
  • Psychosis Research
  • Biomarker Discovery

Background:

  • Magnetic Resonance Imaging (MRI) is crucial for studying individuals at clinical high risk (CHR) for psychosis.
  • Existing studies often lack the statistical power for robust neuroimaging findings.
  • The Accelerating Medicines Partnership® Schizophrenia Program (AMP® SCZ) aims to build a large-scale CHR cohort.

Purpose of the Study:

  • To describe a prospective, advanced neuroimaging protocol for the AMP® SCZ initiative.
  • To establish a standardized multi-site, multi-vendor data acquisition strategy.
  • To analyze sources of variance in neuroimaging data to inform future analyses.

Main Methods:

  • Implemented a protocol including T1/T2-weighted structural MRI, resting-state fMRI, and diffusion-weighted imaging.
  • Collected data from participants at two time points, approximately two months apart.
  • Conducted variance component analyses on signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and spatial smoothness.

Main Results:

  • Site-related variance was generally small (<10%).
  • Participant variance constituted the largest component for structural and fMRI SNR/CNR (40-76%).
  • Substantial platform-related variance (>55%) was observed for diffusion imaging SNR/CNR and spatial smoothness due to scanner and vendor differences.

Conclusions:

  • The described protocol provides a foundation for analyzing the largest CHR neuroimaging dataset to date.
  • Understanding variance sources is critical for robust analysis of multi-site, multi-vendor neuroimaging data.
  • Scanner and acquisition differences significantly impact diffusion imaging quality and spatial smoothness, requiring careful consideration in data analysis.